Maria Sjöberg
Profile
Maria Sjöberg worked as CEO, CSO, and VP-Preclinical Research & Development at Karo Healthcare AB in 2015.
She also worked as Director-Production and Head-Research & Development at SentoClone AB from 2009 to 2012.
Former positions of Maria Sjöberg
| Companies | Position | End |
|---|---|---|
SentoClone AB
 SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Chief Tech/Sci/R&D Officer | 2012-12-30 |
| KARO PHARMA AB (PUBL) | Chief Executive Officer | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| KARO PHARMA AB (PUBL) | Health Technology |
| Private companies | 1 |
|---|---|
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
- Stock Market
- Insiders
- Maria Sjöberg
